Expand HUMA Menu
HUMA MENU

HUMA Latest Press Releases

-- February 9, 2026 --

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels Globe Newswire 8:00 AM

-- January 8, 2026 --

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications Globe Newswire 8:00 AM

-- January 5, 2026 --

Humacyte Announces Planned Marketing Authorization Application for Symvess in Israel Globe Newswire 8:00 AM

-- December 16, 2025 --

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital Globe Newswire 8:00 AM

-- November 20, 2025 --

Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV ) Clinical Results Globe Newswire 8:00 AM

-- November 13, 2025 --

Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) Globe Newswire 8:00 AM

-- November 12, 2025 --

Strong Earnings and Biotech Resilience Define the Midweek Momentum Globe Newswire 11:00 AM
Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- November 10, 2025 --

Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology's Kidney Week 2025 Globe Newswire 8:00 AM

-- November 6, 2025 --

Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 Globe Newswire 8:00 AM

-- October 30, 2025 --

Humacyte Announces Publication of New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma Globe Newswire 8:00 AM

-- October 7, 2025 --

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering Globe Newswire 9:00 AM

-- October 6, 2025 --

Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess Globe Newswire 8:00 AM

-- September 29, 2025 --

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus Globe Newswire 8:00 AM

-- September 18, 2025 --

Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG) Globe Newswire 7:00 AM

-- September 15, 2025 --

Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes